PHOTODYNAMIC THERAPY FOR PENILE LEUKOPLAKIA (CASE REPORT)
https://doi.org/10.24931/2413-9432-2018-7-1-37-40
Abstract
In the publication, the authors present a clinical case of successful application of photodynamic therapy with photolon – a chlorin series photosensitizer, in a young patient with leukoplakia of the glans penis. Photolon was administered in a dose of 2 mg/kg 2.5 hours before photodynamic therapy (light dose 50 J/cm2) The treatment included 3 sessions of photoirradiation with 1 month interval. The authors note complete regression of pathological foci and long-term clinical remission (more than 6 months).
About the Authors
D. A. TzerkovskyBelarus
Lesnoy
T. P. Artemyeva
Belarus
Lesnoy
References
1. Urologiya: ucheb.dlya studentov uchrezhdenii vyssh. prof. Obrazovaniya, obuchayushchikhsya po spetsial'nosti 060101.65 «Lechebnoe delo» po distsipline «Urologiya» [ Urology: a textbook for students of institutions of higher professional education studying in the specialty 060101.65 "Medicine" on the discipline "Urology"] by eds Pushkar’ D.Yu. Moscow, GEOTAR-MEDIA Publ., 2013. 384 p.
2. Rukovodstvo po onkologii. V 2 t. T. II. V 2 kn. kn. 2 [Guide to Oncology in 2 volumes. Vol. II, In 2 books. Book 2] by eds Sukonko O.G. Minsk, Belarus', Enciklodepiya im. P. Brovki Publ., 2016. 440 p.
3. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic Therapy, J. Nat. Cancer Ins., 1998, Vol. 90, No. 12, pp. 889-905.
4. Mroz P., Yaroslavsky A., Kharkwal G.B., Hamblin M.R. Cell death pathways in photodynamic therapy of tumors, Cancers, 2011, Vol. 3(2), pp. 2516-2539.
5. Rapozzi V., Jori G. Resistance to photodynamic therapy in cancer. Switzerland, Springer, 2015. 251 p.
6. Abder-Kader M.H. Photodynamic therapy. From theory to application. Verlag, Berlin, Heidelberg, Springer, 2014. 317 p.
Review
For citations:
Tzerkovsky D.A., Artemyeva T.P. PHOTODYNAMIC THERAPY FOR PENILE LEUKOPLAKIA (CASE REPORT). Biomedical Photonics. 2018;7(1):37-40. (In Russ.) https://doi.org/10.24931/2413-9432-2018-7-1-37-40